Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Valk BioTech AB
AB
Active
Org 5594442906
Skrivargatan 31, 174 64
Sundbyberg
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2023
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Valk BioTech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2024
Income statement
SEK thousands
Item
2024
Revenue
657
Staff expenses
—
EBITDA
587
Depreciation & amort.
—
EBIT
587
Net financials
5
Profit before tax
591
Tax
−124
Net profit
467
Balance sheet
SEK thousands
Item
2024
Total assets
618
Equity
492
Long-term debt
—
Short-term debt
126
Total debt
126
Financial ratios
5-year trend
EBITDA margin
89.3%
This company
15.8%
Market median
+465% vs market
2024
2024
Equity ratio
79.6%
This company
38.2%
Market median
+108% vs market
2024
2024
Return on equity
94.9%
This company
18.4%
Market median
+416% vs market
2024
2024
Net profit margin
71.1%
This company
8.1%
Market median
+778% vs market
2024
2024
Asset turnover
1.06×
This company
1.12×
Market median
+5% vs market
2024
2024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-08-11 – 2024-12-31
View
PDF
More on Valk BioTech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
